These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4020150)

  • 1. A short-duration polyethylene glycol fusion technique for increasing production of monoclonal antibody-secreting hybridomas.
    Lane RD
    J Immunol Methods; 1985 Aug; 81(2):223-8. PubMed ID: 4020150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of polyethylene glycols as fusogens for producing lymphocyte-myeloma hybrids.
    Lane RD; Crissman RS; Lachman MF
    J Immunol Methods; 1984 Aug; 72(1):71-6. PubMed ID: 6747307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylene Glycol Fusion for Hybridoma Production.
    Greenfield EA
    Cold Spring Harb Protoc; 2018 Mar; 2018(3):. PubMed ID: 29496822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF; Hawley RG; Hawley TS; Crawford-Sharpe GC
    J Immunol Methods; 1992 Apr; 148(1-2):199-207. PubMed ID: 1373425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
    Strike LE; Devens BH; Lundak RL
    J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efforts to produce human cytotoxic T-cell hybridomas by electrofusion and PEG fusion.
    Gravekamp C; Santoli D; Vreugdenhil R; Collard JG; Bolhuis RL
    Hybridoma; 1987 Apr; 6(2):121-33. PubMed ID: 3494659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells.
    Orlik O; Altaner C
    J Immunol Methods; 1988 Nov; 115(1):55-9. PubMed ID: 2848072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient generation of stable antibody forming hybridoma cells by electrofusion.
    Schmitt JJ; Zimmermann U; Neil GA
    Hybridoma; 1989 Feb; 8(1):107-15. PubMed ID: 2925206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.
    Tomita M; Fukuda T; Ozu A; Kimura K; Tsong TY; Yoshimura T
    Hybridoma (Larchmt); 2006 Oct; 25(5):283-92. PubMed ID: 17044784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contamination of polyethylene glycol with aldehydes: implications for hybridoma fusion.
    Kadish JL; Wenc KM
    Hybridoma; 1983; 2(1):87-9. PubMed ID: 6678796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High yields of specific hybridomas obtained by electrofusion of murine lymphocytes immunized in vivo or in vitro.
    van Duijn G; Langedijk JP; de Boer M; Tager JM
    Exp Cell Res; 1989 Aug; 183(2):463-72. PubMed ID: 2767160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The addition of insulin to HAT medium (HIAT) enhances hybridoma formation.
    Bartal AH; Feit C; Hirshaut Y
    Dev Biol Stand; 1984; 57():27-33. PubMed ID: 6396129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of hybridoma production by medium supplemented with murine ascitic fluid.
    Stewart SS; Fuller SA
    J Immunol Methods; 1989 Sep; 123(1):45-53. PubMed ID: 2794529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential generation of monoclonal IgG-producing hybridomas by use of vesicular stomatitis virus-mediated cell fusion.
    Nagata S; Yamamoto K; Ueno Y; Kurata T; Chiba J
    Hybridoma; 1991 Jun; 10(3):369-78. PubMed ID: 1655635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
    Kato M; Sasamori E; Chiba T; Hanyu Y
    J Immunol Methods; 2011 Oct; 373(1-2):102-10. PubMed ID: 21878337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrofusion between heterogeneous-sized mammalian cells in a pellet: potential applications in drug delivery and hybridoma formation.
    Li LH; Hensen ML; Zhao YL; Hui SW
    Biophys J; 1996 Jul; 71(1):479-86. PubMed ID: 8804630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of electric field-mediated and PEG-mediated cell fusion for the generation of antibody producing hybridomas.
    Karsten U; Stolley P; Walther I; Papsdorf G; Weber S; Conrad K; Pasternak L; Kopp J
    Hybridoma; 1988 Dec; 7(6):627-33. PubMed ID: 3235098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid generation of monoclonal antibody-secreting hybridomas against African horse sickness virus by in vitro immunization and the fusion/cloning technique.
    Stäuber N; Kihm U; McCullough KC
    J Immunol Methods; 1993 May; 161(2):157-68. PubMed ID: 8505546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid isolation of monoclonal hybridoma cultures by a 'fusion-cloning' method: the requirement for aminopterin.
    Butcher RN; Obi TU; McCullough KC
    Biologicals; 1991 Jul; 19(3):171-5. PubMed ID: 1954000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.